Corporate Philanthropy - Best Practices at Novartis AG
|
|
ICMR HOME | Case Studies Collection
To download Corporate Philanthropy - Best Practices at Novartis AG case study
(Case Code: BECG063) click on the button below, and select the case from the list of available cases:
OR
Buy With PayPal
|
» Business Ethics Case Studies
» Case Studies Collection
» ICMR Home
» Business Ethics Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
Case Details: |
Price: |
| Case Code |
: |
BECG063 |
For delivery in electronic format: Rs. 500 ;
For delivery through Shipping & Handling Charges extra: Rs. 500 +Shipping & Handling Charges extra
ThemesCorporate Philanthropy, Corporate Citizenship, Social Responsibility |
| Case Length |
: |
23 Pages |
| Period |
: |
2000-06 |
| Organization |
: |
Novartis AG,
Novartis Foundation for Sustainable |
| Pub Date |
: |
2006 |
| Teaching Note |
: |
Available |
| Countries
|
: |
Switzerland |
| Industry |
: |
Pharmaceutical |
Abstract:
|
The case discusses the corporate philanthropy initiatives of Switzerland based
pharma major Novartis AG. Even before Novartis was incorporated in 1996, through
the merger of Ciba Geigy and Sandoz; Ciba Geigy was actively involved in
philanthropic activities and had set up a foundation in 1979, which went on to
become Novartis Foundation after the merger. Novartis also adopted the UN Global
Compact principles in the year 2000. Novartis and Novartis Foundation were
actively involved in several philanthropic projects to help the poor in
underdeveloped countries. The case discusses in detail few such projects like
anti-leprosy program, initiatives to eliminate malaria and tuberculosis (TB),
and programs for AIDS orphans etc.
|
|
The company also started a research institute
to carryout research on tropical diseases. The institute was
actively involved in finding cure for dengue fever and TB. The
philanthropic activities of Novartis were extended to include
poor people of the developed countries, and the company started
providing its highly effective cancer drug Gleevec in the US
free of cost for patients whose income was low.
Issues:
» Study and analyze the importance of philanthropy initiatives by organizations
» Determine the rationale for corporate philanthropic activities and how to make
them sustainable
» Evaluate how corporates can play their part in the development of the society
» Understand the principles of the UN Global Compact and its implementation by
Novartis
Contents:
Keywords:
Novartis AG, Novartis Foundation for Sustainable Development,
Corporate Philanthropy, Social Responsibility , Sustainability Management, UN
Global Compact, Access to Medicines Program, Novartis Code of Conduct, Social
Marketing, Corporate Citizenship
Corporate Philanthropy - Best Practices at Novartis AG
- Next Page>>
|
|
